nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—GABBR1—Vigabatrin—epilepsy syndrome	0.27	0.974	CbGbCtD
Baclofen—GABBR1—epilepsy syndrome	0.243	1	CbGaD
Baclofen—multiple sclerosis—Diazepam—epilepsy syndrome	0.0615	0.213	CpDpCtD
Baclofen—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0615	0.213	CpDpCtD
Baclofen—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0523	0.181	CpDpCtD
Baclofen—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0466	0.161	CpDpCtD
Baclofen—multiple sclerosis—Clonazepam—epilepsy syndrome	0.0372	0.129	CpDpCtD
Baclofen—multiple sclerosis—Gabapentin—epilepsy syndrome	0.03	0.104	CpDpCtD
Baclofen—SLC22A8—Valproic Acid—epilepsy syndrome	0.00723	0.0261	CbGbCtD
Baclofen—GABBR2—hindbrain—epilepsy syndrome	0.00351	0.154	CbGeAlD
Baclofen—GABBR2—brainstem—epilepsy syndrome	0.00201	0.0884	CbGeAlD
Baclofen—GABBR2—forebrain—epilepsy syndrome	0.00194	0.0853	CbGeAlD
Baclofen—GABBR2—telencephalon—epilepsy syndrome	0.00179	0.0785	CbGeAlD
Baclofen—GABBR2—medulla oblongata—epilepsy syndrome	0.0014	0.0617	CbGeAlD
Baclofen—GABBR2—midbrain—epilepsy syndrome	0.00128	0.0564	CbGeAlD
Baclofen—GABBR2—spinal cord—epilepsy syndrome	0.00125	0.055	CbGeAlD
Baclofen—GABBR2—head—epilepsy syndrome	0.00111	0.0489	CbGeAlD
Baclofen—GABBR2—nervous system—epilepsy syndrome	0.00105	0.0463	CbGeAlD
Baclofen—GABBR2—central nervous system—epilepsy syndrome	0.00101	0.0446	CbGeAlD
Baclofen—GABBR2—cerebellum—epilepsy syndrome	0.000992	0.0436	CbGeAlD
Baclofen—GABBR1—telencephalon—epilepsy syndrome	0.000901	0.0396	CbGeAlD
Baclofen—GABBR2—brain—epilepsy syndrome	0.000806	0.0354	CbGeAlD
Baclofen—GABBR1—medulla oblongata—epilepsy syndrome	0.000708	0.0311	CbGeAlD
Baclofen—GABBR1—midbrain—epilepsy syndrome	0.000647	0.0284	CbGeAlD
Baclofen—GABBR1—spinal cord—epilepsy syndrome	0.000631	0.0277	CbGeAlD
Baclofen—GABBR1—cerebellum—epilepsy syndrome	0.0005	0.022	CbGeAlD
Baclofen—GABBR1—brain—epilepsy syndrome	0.000407	0.0179	CbGeAlD
Baclofen—Ibuprofen—PLAT—epilepsy syndrome	0.000288	0.189	CrCbGaD
Baclofen—Chlorpropamide—KCNJ11—epilepsy syndrome	0.00028	0.184	CrCbGaD
Baclofen—SLC22A8—head—epilepsy syndrome	0.000222	0.00974	CbGeAlD
Baclofen—SLC22A8—nervous system—epilepsy syndrome	0.00021	0.00923	CbGeAlD
Baclofen—SLC22A8—central nervous system—epilepsy syndrome	0.000202	0.00889	CbGeAlD
Baclofen—Chlorphenesin—BCHE—epilepsy syndrome	0.000188	0.123	CrCbGaD
Baclofen—Ibuprofen—SLCO1A2—epilepsy syndrome	0.000187	0.123	CrCbGaD
Baclofen—Ibuprofen—BCL2—epilepsy syndrome	0.000165	0.108	CrCbGaD
Baclofen—SLC22A8—brain—epilepsy syndrome	0.000161	0.00706	CbGeAlD
Baclofen—Chlorpropamide—CYP2C19—epilepsy syndrome	0.000105	0.0692	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—epilepsy syndrome	8.66e-05	0.0568	CrCbGaD
Baclofen—Ibuprofen—CYP2C19—epilepsy syndrome	6.21e-05	0.0407	CrCbGaD
Baclofen—Chlorpropamide—ABCB1—epilepsy syndrome	5.58e-05	0.0366	CrCbGaD
Baclofen—Ibuprofen—PTGS2—epilepsy syndrome	3.87e-05	0.0254	CrCbGaD
Baclofen—Ibuprofen—ALB—epilepsy syndrome	3.44e-05	0.0226	CrCbGaD
Baclofen—Ibuprofen—ABCB1—epilepsy syndrome	3.29e-05	0.0216	CrCbGaD
Baclofen—GABBR2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.46e-05	0.000215	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GAL—epilepsy syndrome	1.46e-05	0.000215	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GFAP—epilepsy syndrome	1.46e-05	0.000215	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT3—epilepsy syndrome	1.46e-05	0.000214	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRM5—epilepsy syndrome	1.45e-05	0.000213	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP2—epilepsy syndrome	1.45e-05	0.000213	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CHRM3—epilepsy syndrome	1.45e-05	0.000213	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.44e-05	0.000212	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCR3—epilepsy syndrome	1.42e-05	0.000208	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AVP—epilepsy syndrome	1.42e-05	0.000208	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.39e-05	0.000204	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	1.38e-05	0.000204	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HRH3—epilepsy syndrome	1.38e-05	0.000203	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.38e-05	0.000203	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.38e-05	0.000203	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.38e-05	0.000203	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.38e-05	0.000203	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—NPY—epilepsy syndrome	1.38e-05	0.000203	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCR5—epilepsy syndrome	1.37e-05	0.000202	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—OPRM1—epilepsy syndrome	1.36e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.36e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CHRM2—epilepsy syndrome	1.36e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM2—epilepsy syndrome	1.36e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.36e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—HTR2A—epilepsy syndrome	1.34e-05	0.000198	CbGpPWpGaD
Baclofen—Dermatitis—Vigabatrin—epilepsy syndrome	1.33e-05	0.000135	CcSEcCtD
Baclofen—Urethral disorder—Topiramate—epilepsy syndrome	1.33e-05	0.000135	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	1.33e-05	0.000196	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—OXT—epilepsy syndrome	1.33e-05	0.000196	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CRH—epilepsy syndrome	1.33e-05	0.000196	CbGpPWpGaD
Baclofen—Pruritus—Oxcarbazepine—epilepsy syndrome	1.33e-05	0.000134	CcSEcCtD
Baclofen—Convulsion—Pregabalin—epilepsy syndrome	1.33e-05	0.000134	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CDC42—epilepsy syndrome	1.33e-05	0.000195	CbGpPWpGaD
Baclofen—Vision blurred—Gabapentin—epilepsy syndrome	1.33e-05	0.000134	CcSEcCtD
Baclofen—Headache—Vigabatrin—epilepsy syndrome	1.33e-05	0.000134	CcSEcCtD
Baclofen—Hypertension—Pregabalin—epilepsy syndrome	1.33e-05	0.000134	CcSEcCtD
Baclofen—Vomiting—Diazepam—epilepsy syndrome	1.33e-05	0.000134	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—GABBR1—epilepsy syndrome	1.32e-05	0.000194	CbGpPWpGaD
Baclofen—Anorexia—Valproic Acid—epilepsy syndrome	1.32e-05	0.000133	CcSEcCtD
Baclofen—Tremor—Gabapentin—epilepsy syndrome	1.32e-05	0.000133	CcSEcCtD
Baclofen—Rash—Diazepam—epilepsy syndrome	1.31e-05	0.000133	CcSEcCtD
Baclofen—Dermatitis—Diazepam—epilepsy syndrome	1.31e-05	0.000133	CcSEcCtD
Baclofen—Visual impairment—Topiramate—epilepsy syndrome	1.31e-05	0.000132	CcSEcCtD
Baclofen—Chest pain—Pregabalin—epilepsy syndrome	1.31e-05	0.000132	CcSEcCtD
Baclofen—Myalgia—Pregabalin—epilepsy syndrome	1.31e-05	0.000132	CcSEcCtD
Baclofen—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.31e-05	0.000132	CcSEcCtD
Baclofen—Dizziness—Zonisamide—epilepsy syndrome	1.31e-05	0.000132	CcSEcCtD
Baclofen—Headache—Diazepam—epilepsy syndrome	1.31e-05	0.000132	CcSEcCtD
Baclofen—Anxiety—Pregabalin—epilepsy syndrome	1.3e-05	0.000131	CcSEcCtD
Baclofen—Diarrhoea—Clonazepam—epilepsy syndrome	1.3e-05	0.000131	CcSEcCtD
Baclofen—Anaemia—Gabapentin—epilepsy syndrome	1.3e-05	0.000131	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.3e-05	0.000131	CcSEcCtD
Baclofen—Hypotension—Valproic Acid—epilepsy syndrome	1.3e-05	0.000131	CcSEcCtD
Baclofen—Asthenia—Carbamazepine—epilepsy syndrome	1.29e-05	0.000131	CcSEcCtD
Baclofen—Agitation—Gabapentin—epilepsy syndrome	1.29e-05	0.000131	CcSEcCtD
Baclofen—Diarrhoea—Phenytoin—epilepsy syndrome	1.29e-05	0.000131	CcSEcCtD
Baclofen—Discomfort—Pregabalin—epilepsy syndrome	1.29e-05	0.00013	CcSEcCtD
Baclofen—Nausea—Fosphenytoin—epilepsy syndrome	1.29e-05	0.00013	CcSEcCtD
Baclofen—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.29e-05	0.00013	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AVP—epilepsy syndrome	1.29e-05	0.000189	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCR3—epilepsy syndrome	1.29e-05	0.000189	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.28e-05	0.000189	CbGpPWpGaD
Baclofen—Vomiting—Felbamate—epilepsy syndrome	1.28e-05	0.00013	CcSEcCtD
Baclofen—Dry mouth—Pregabalin—epilepsy syndrome	1.28e-05	0.000129	CcSEcCtD
Baclofen—Pruritus—Carbamazepine—epilepsy syndrome	1.28e-05	0.000129	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—AGT—epilepsy syndrome	1.27e-05	0.000187	CbGpPWpGaD
Baclofen—Rash—Felbamate—epilepsy syndrome	1.27e-05	0.000128	CcSEcCtD
Baclofen—Eye disorder—Topiramate—epilepsy syndrome	1.27e-05	0.000128	CcSEcCtD
Baclofen—Dermatitis—Felbamate—epilepsy syndrome	1.27e-05	0.000128	CcSEcCtD
Baclofen—Malaise—Gabapentin—epilepsy syndrome	1.27e-05	0.000128	CcSEcCtD
Baclofen—Tinnitus—Topiramate—epilepsy syndrome	1.27e-05	0.000128	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HRH3—epilepsy syndrome	1.27e-05	0.000186	CbGpPWpGaD
Baclofen—Vertigo—Gabapentin—epilepsy syndrome	1.26e-05	0.000128	CcSEcCtD
Baclofen—Headache—Felbamate—epilepsy syndrome	1.26e-05	0.000128	CcSEcCtD
Baclofen—Confusional state—Pregabalin—epilepsy syndrome	1.26e-05	0.000128	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.26e-05	0.000127	CcSEcCtD
Baclofen—Flushing—Topiramate—epilepsy syndrome	1.26e-05	0.000127	CcSEcCtD
Baclofen—Cardiac disorder—Topiramate—epilepsy syndrome	1.26e-05	0.000127	CcSEcCtD
Baclofen—Syncope—Gabapentin—epilepsy syndrome	1.26e-05	0.000127	CcSEcCtD
Baclofen—Dizziness—Clonazepam—epilepsy syndrome	1.26e-05	0.000127	CcSEcCtD
Baclofen—Nausea—Vigabatrin—epilepsy syndrome	1.26e-05	0.000127	CcSEcCtD
Baclofen—Vomiting—Zonisamide—epilepsy syndrome	1.26e-05	0.000127	CcSEcCtD
Baclofen—Insomnia—Valproic Acid—epilepsy syndrome	1.25e-05	0.000127	CcSEcCtD
Baclofen—Oedema—Pregabalin—epilepsy syndrome	1.25e-05	0.000126	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—NPY—epilepsy syndrome	1.25e-05	0.000184	CbGpPWpGaD
Baclofen—Asthenia—Lamotrigine—epilepsy syndrome	1.25e-05	0.000126	CcSEcCtD
Baclofen—Dizziness—Phenytoin—epilepsy syndrome	1.25e-05	0.000126	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—OPRM1—epilepsy syndrome	1.25e-05	0.000184	CbGpPWpGaD
Baclofen—Rash—Zonisamide—epilepsy syndrome	1.25e-05	0.000126	CcSEcCtD
Baclofen—Infection—Pregabalin—epilepsy syndrome	1.24e-05	0.000126	CcSEcCtD
Baclofen—Paraesthesia—Valproic Acid—epilepsy syndrome	1.24e-05	0.000126	CcSEcCtD
Baclofen—Palpitations—Gabapentin—epilepsy syndrome	1.24e-05	0.000126	CcSEcCtD
Baclofen—Dermatitis—Zonisamide—epilepsy syndrome	1.24e-05	0.000126	CcSEcCtD
Baclofen—Dizziness—Oxcarbazepine—epilepsy syndrome	1.24e-05	0.000126	CcSEcCtD
Baclofen—Nausea—Diazepam—epilepsy syndrome	1.24e-05	0.000125	CcSEcCtD
Baclofen—Loss of consciousness—Gabapentin—epilepsy syndrome	1.24e-05	0.000125	CcSEcCtD
Baclofen—Headache—Zonisamide—epilepsy syndrome	1.24e-05	0.000125	CcSEcCtD
Baclofen—Dyspnoea—Valproic Acid—epilepsy syndrome	1.24e-05	0.000125	CcSEcCtD
Baclofen—Diarrhoea—Carbamazepine—epilepsy syndrome	1.23e-05	0.000125	CcSEcCtD
Baclofen—Angiopathy—Topiramate—epilepsy syndrome	1.23e-05	0.000125	CcSEcCtD
Baclofen—Pruritus—Lamotrigine—epilepsy syndrome	1.23e-05	0.000125	CcSEcCtD
Baclofen—Shock—Pregabalin—epilepsy syndrome	1.23e-05	0.000124	CcSEcCtD
Baclofen—Somnolence—Valproic Acid—epilepsy syndrome	1.23e-05	0.000124	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SSTR3—epilepsy syndrome	1.23e-05	0.000181	CbGpPWpGaD
Baclofen—Nervous system disorder—Pregabalin—epilepsy syndrome	1.23e-05	0.000124	CcSEcCtD
Baclofen—Mediastinal disorder—Topiramate—epilepsy syndrome	1.23e-05	0.000124	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.23e-05	0.00018	CbGpPWpGaD
Baclofen—Tachycardia—Pregabalin—epilepsy syndrome	1.22e-05	0.000123	CcSEcCtD
Baclofen—Chills—Topiramate—epilepsy syndrome	1.22e-05	0.000123	CcSEcCtD
Baclofen—Dyspepsia—Valproic Acid—epilepsy syndrome	1.22e-05	0.000123	CcSEcCtD
Baclofen—Convulsion—Gabapentin—epilepsy syndrome	1.22e-05	0.000123	CcSEcCtD
Baclofen—Skin disorder—Pregabalin—epilepsy syndrome	1.22e-05	0.000123	CcSEcCtD
Baclofen—Hypertension—Gabapentin—epilepsy syndrome	1.22e-05	0.000123	CcSEcCtD
Baclofen—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.21e-05	0.000122	CcSEcCtD
Baclofen—Vomiting—Clonazepam—epilepsy syndrome	1.21e-05	0.000122	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CCL3—epilepsy syndrome	1.21e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CRH—epilepsy syndrome	1.21e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—OXT—epilepsy syndrome	1.21e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL2—epilepsy syndrome	1.21e-05	0.000178	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.21e-05	0.000178	CbGpPWpGaD
Baclofen—Decreased appetite—Valproic Acid—epilepsy syndrome	1.2e-05	0.000122	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.2e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—SST—epilepsy syndrome	1.2e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.2e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.2e-05	0.000177	CbGpPWpGaD
Baclofen—Alopecia—Topiramate—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Vomiting—Phenytoin—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Rash—Clonazepam—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Dermatitis—Clonazepam—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Myalgia—Gabapentin—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Chest pain—Gabapentin—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Nausea—Felbamate—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Vomiting—Oxcarbazepine—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Fatigue—Valproic Acid—epilepsy syndrome	1.2e-05	0.000121	CcSEcCtD
Baclofen—Anxiety—Gabapentin—epilepsy syndrome	1.19e-05	0.000121	CcSEcCtD
Baclofen—Anorexia—Pregabalin—epilepsy syndrome	1.19e-05	0.000121	CcSEcCtD
Baclofen—Dizziness—Carbamazepine—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Diarrhoea—Lamotrigine—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Headache—Clonazepam—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Rash—Phenytoin—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Mental disorder—Topiramate—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Dermatitis—Phenytoin—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Rash—Oxcarbazepine—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Constipation—Valproic Acid—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Pain—Valproic Acid—epilepsy syndrome	1.19e-05	0.00012	CcSEcCtD
Baclofen—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.18e-05	0.00012	CcSEcCtD
Baclofen—Headache—Phenytoin—epilepsy syndrome	1.18e-05	0.00012	CcSEcCtD
Baclofen—Malnutrition—Topiramate—epilepsy syndrome	1.18e-05	0.00012	CcSEcCtD
Baclofen—Discomfort—Gabapentin—epilepsy syndrome	1.18e-05	0.00012	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCR3—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR8—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SSTR1—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NPY2R—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR9—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—Headache—Oxcarbazepine—epilepsy syndrome	1.18e-05	0.000119	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.18e-05	0.000173	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.17e-05	0.000173	CbGpPWpGaD
Baclofen—Nausea—Zonisamide—epilepsy syndrome	1.17e-05	0.000118	CcSEcCtD
Baclofen—Dry mouth—Gabapentin—epilepsy syndrome	1.17e-05	0.000118	CcSEcCtD
Baclofen—Hypotension—Pregabalin—epilepsy syndrome	1.17e-05	0.000118	CcSEcCtD
Baclofen—Flatulence—Topiramate—epilepsy syndrome	1.17e-05	0.000118	CcSEcCtD
Baclofen—Dysgeusia—Topiramate—epilepsy syndrome	1.16e-05	0.000117	CcSEcCtD
Baclofen—Confusional state—Gabapentin—epilepsy syndrome	1.16e-05	0.000117	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GRM4—epilepsy syndrome	1.16e-05	0.00017	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM3—epilepsy syndrome	1.16e-05	0.00017	CbGpPWpGaD
Baclofen—Dizziness—Lamotrigine—epilepsy syndrome	1.15e-05	0.000116	CcSEcCtD
Baclofen—Oedema—Gabapentin—epilepsy syndrome	1.15e-05	0.000116	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NPY—epilepsy syndrome	1.15e-05	0.000169	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.15e-05	0.000169	CbGpPWpGaD
Baclofen—Vomiting—Carbamazepine—epilepsy syndrome	1.15e-05	0.000116	CcSEcCtD
Baclofen—Back pain—Topiramate—epilepsy syndrome	1.15e-05	0.000116	CcSEcCtD
Baclofen—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.14e-05	0.000115	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.14e-05	0.000115	CcSEcCtD
Baclofen—Infection—Gabapentin—epilepsy syndrome	1.14e-05	0.000115	CcSEcCtD
Baclofen—Rash—Carbamazepine—epilepsy syndrome	1.14e-05	0.000115	CcSEcCtD
Baclofen—Dermatitis—Carbamazepine—epilepsy syndrome	1.14e-05	0.000115	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—DUSP4—epilepsy syndrome	1.13e-05	0.000167	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SSTR2—epilepsy syndrome	1.13e-05	0.000167	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.13e-05	0.000114	CcSEcCtD
Baclofen—Insomnia—Pregabalin—epilepsy syndrome	1.13e-05	0.000114	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.13e-05	0.000166	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.13e-05	0.000166	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.13e-05	0.000166	CbGpPWpGaD
Baclofen—Nausea—Clonazepam—epilepsy syndrome	1.13e-05	0.000114	CcSEcCtD
Baclofen—Headache—Carbamazepine—epilepsy syndrome	1.13e-05	0.000114	CcSEcCtD
Baclofen—Shock—Gabapentin—epilepsy syndrome	1.13e-05	0.000114	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	1.13e-05	0.000166	CbGpPWpGaD
Baclofen—Nervous system disorder—Gabapentin—epilepsy syndrome	1.13e-05	0.000114	CcSEcCtD
Baclofen—Paraesthesia—Pregabalin—epilepsy syndrome	1.13e-05	0.000114	CcSEcCtD
Baclofen—Nausea—Phenytoin—epilepsy syndrome	1.12e-05	0.000113	CcSEcCtD
Baclofen—Tachycardia—Gabapentin—epilepsy syndrome	1.12e-05	0.000113	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—AGT—epilepsy syndrome	1.12e-05	0.000164	CbGpPWpGaD
Baclofen—Dyspnoea—Pregabalin—epilepsy syndrome	1.12e-05	0.000113	CcSEcCtD
Baclofen—Nausea—Oxcarbazepine—epilepsy syndrome	1.12e-05	0.000113	CcSEcCtD
Baclofen—Vision blurred—Topiramate—epilepsy syndrome	1.12e-05	0.000113	CcSEcCtD
Baclofen—Skin disorder—Gabapentin—epilepsy syndrome	1.12e-05	0.000113	CcSEcCtD
Baclofen—Somnolence—Pregabalin—epilepsy syndrome	1.11e-05	0.000112	CcSEcCtD
Baclofen—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.11e-05	0.000112	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.11e-05	0.000163	CbGpPWpGaD
Baclofen—Tremor—Topiramate—epilepsy syndrome	1.11e-05	0.000112	CcSEcCtD
Baclofen—Vomiting—Lamotrigine—epilepsy syndrome	1.11e-05	0.000112	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HSPB1—epilepsy syndrome	1.11e-05	0.000163	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—OXT—epilepsy syndrome	1.11e-05	0.000163	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL2—epilepsy syndrome	1.11e-05	0.000163	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL3—epilepsy syndrome	1.11e-05	0.000163	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CRH—epilepsy syndrome	1.11e-05	0.000163	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.11e-05	0.000163	CbGpPWpGaD
Baclofen—Urticaria—Valproic Acid—epilepsy syndrome	1.1e-05	0.000111	CcSEcCtD
Baclofen—Rash—Lamotrigine—epilepsy syndrome	1.1e-05	0.000111	CcSEcCtD
Baclofen—Ill-defined disorder—Topiramate—epilepsy syndrome	1.1e-05	0.000111	CcSEcCtD
Baclofen—Dermatitis—Lamotrigine—epilepsy syndrome	1.1e-05	0.000111	CcSEcCtD
Baclofen—Abdominal pain—Valproic Acid—epilepsy syndrome	1.1e-05	0.000111	CcSEcCtD
Baclofen—Body temperature increased—Valproic Acid—epilepsy syndrome	1.1e-05	0.000111	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GRM8—epilepsy syndrome	1.1e-05	0.000161	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PGF—epilepsy syndrome	1.1e-05	0.000161	CbGpPWpGaD
Baclofen—Anorexia—Gabapentin—epilepsy syndrome	1.1e-05	0.000111	CcSEcCtD
Baclofen—Anaemia—Topiramate—epilepsy syndrome	1.09e-05	0.000111	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCR5—epilepsy syndrome	1.09e-05	0.000161	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCR2—epilepsy syndrome	1.09e-05	0.000161	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SST—epilepsy syndrome	1.09e-05	0.000161	CbGpPWpGaD
Baclofen—Headache—Lamotrigine—epilepsy syndrome	1.09e-05	0.00011	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.09e-05	0.000161	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.09e-05	0.000161	CbGpPWpGaD
Baclofen—Decreased appetite—Pregabalin—epilepsy syndrome	1.09e-05	0.00011	CcSEcCtD
Baclofen—Agitation—Topiramate—epilepsy syndrome	1.09e-05	0.00011	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.08e-05	0.000159	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.08e-05	0.000109	CcSEcCtD
Baclofen—Fatigue—Pregabalin—epilepsy syndrome	1.08e-05	0.000109	CcSEcCtD
Baclofen—Hypotension—Gabapentin—epilepsy syndrome	1.07e-05	0.000108	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—POMC—epilepsy syndrome	1.07e-05	0.000158	CbGpPWpGaD
Baclofen—Nausea—Carbamazepine—epilepsy syndrome	1.07e-05	0.000108	CcSEcCtD
Baclofen—Pain—Pregabalin—epilepsy syndrome	1.07e-05	0.000108	CcSEcCtD
Baclofen—Constipation—Pregabalin—epilepsy syndrome	1.07e-05	0.000108	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.07e-05	0.000157	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.07e-05	0.000157	CbGpPWpGaD
Baclofen—Malaise—Topiramate—epilepsy syndrome	1.07e-05	0.000108	CcSEcCtD
Baclofen—Vertigo—Topiramate—epilepsy syndrome	1.06e-05	0.000107	CcSEcCtD
Baclofen—Syncope—Topiramate—epilepsy syndrome	1.06e-05	0.000107	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CCL2—epilepsy syndrome	1.05e-05	0.000154	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.05e-05	0.000154	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.05e-05	0.000106	CcSEcCtD
Baclofen—Palpitations—Topiramate—epilepsy syndrome	1.05e-05	0.000106	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—OPRD1—epilepsy syndrome	1.05e-05	0.000154	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GNAO1—epilepsy syndrome	1.05e-05	0.000154	CbGpPWpGaD
Baclofen—Loss of consciousness—Topiramate—epilepsy syndrome	1.04e-05	0.000105	CcSEcCtD
Baclofen—Insomnia—Gabapentin—epilepsy syndrome	1.04e-05	0.000105	CcSEcCtD
Baclofen—Nausea—Lamotrigine—epilepsy syndrome	1.04e-05	0.000105	CcSEcCtD
Baclofen—Feeling abnormal—Pregabalin—epilepsy syndrome	1.03e-05	0.000104	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Baclofen—Paraesthesia—Gabapentin—epilepsy syndrome	1.03e-05	0.000104	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—TSC1—epilepsy syndrome	1.03e-05	0.000151	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTK2B—epilepsy syndrome	1.03e-05	0.000151	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.03e-05	0.000151	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.03e-05	0.000151	CbGpPWpGaD
Baclofen—Convulsion—Topiramate—epilepsy syndrome	1.03e-05	0.000104	CcSEcCtD
Baclofen—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.02e-05	0.000103	CcSEcCtD
Baclofen—Dyspnoea—Gabapentin—epilepsy syndrome	1.02e-05	0.000103	CcSEcCtD
Baclofen—Hypertension—Topiramate—epilepsy syndrome	1.02e-05	0.000103	CcSEcCtD
Baclofen—Somnolence—Gabapentin—epilepsy syndrome	1.02e-05	0.000103	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AGT—epilepsy syndrome	1.01e-05	0.000149	CbGpPWpGaD
Baclofen—Dyspepsia—Gabapentin—epilepsy syndrome	1.01e-05	0.000102	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CNR1—epilepsy syndrome	1.01e-05	0.000148	CbGpPWpGaD
Baclofen—Myalgia—Topiramate—epilepsy syndrome	1.01e-05	0.000102	CcSEcCtD
Baclofen—Chest pain—Topiramate—epilepsy syndrome	1.01e-05	0.000102	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PLCB1—epilepsy syndrome	1e-05	0.000148	CbGpPWpGaD
Baclofen—Anxiety—Topiramate—epilepsy syndrome	1e-05	0.000101	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCR2—epilepsy syndrome	1e-05	0.000147	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NTRK2—epilepsy syndrome	1e-05	0.000147	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SST—epilepsy syndrome	1e-05	0.000147	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CHRM1—epilepsy syndrome	1e-05	0.000147	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM1—epilepsy syndrome	1e-05	0.000147	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR7—epilepsy syndrome	1e-05	0.000147	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDYN—epilepsy syndrome	1e-05	0.000147	CbGpPWpGaD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1e-05	0.000101	CcSEcCtD
Baclofen—Decreased appetite—Gabapentin—epilepsy syndrome	9.99e-06	0.000101	CcSEcCtD
Baclofen—Discomfort—Topiramate—epilepsy syndrome	9.96e-06	0.000101	CcSEcCtD
Baclofen—Urticaria—Pregabalin—epilepsy syndrome	9.96e-06	0.0001	CcSEcCtD
Baclofen—Asthenia—Valproic Acid—epilepsy syndrome	9.95e-06	0.0001	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—DUSP6—epilepsy syndrome	9.93e-06	0.000146	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.92e-06	0.0001	CcSEcCtD
Baclofen—Fatigue—Gabapentin—epilepsy syndrome	9.91e-06	0.0001	CcSEcCtD
Baclofen—Abdominal pain—Pregabalin—epilepsy syndrome	9.91e-06	0.0001	CcSEcCtD
Baclofen—Body temperature increased—Pregabalin—epilepsy syndrome	9.91e-06	0.0001	CcSEcCtD
Baclofen—Dry mouth—Topiramate—epilepsy syndrome	9.86e-06	9.96e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—HTR7—epilepsy syndrome	9.84e-06	0.000145	CbGpPWpGaD
Baclofen—Pain—Gabapentin—epilepsy syndrome	9.83e-06	9.92e-05	CcSEcCtD
Baclofen—Constipation—Gabapentin—epilepsy syndrome	9.83e-06	9.92e-05	CcSEcCtD
Baclofen—Pruritus—Valproic Acid—epilepsy syndrome	9.81e-06	9.9e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.8e-06	0.000144	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PLAT—epilepsy syndrome	9.76e-06	0.000144	CbGpPWpGaD
Baclofen—Confusional state—Topiramate—epilepsy syndrome	9.75e-06	9.84e-05	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	9.73e-06	0.000143	CbGpPWpGaD
Baclofen—Oedema—Topiramate—epilepsy syndrome	9.67e-06	9.76e-05	CcSEcCtD
Baclofen—Infection—Topiramate—epilepsy syndrome	9.6e-06	9.69e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—HBEGF—epilepsy syndrome	9.55e-06	0.00014	CbGpPWpGaD
Baclofen—Shock—Topiramate—epilepsy syndrome	9.51e-06	9.6e-05	CcSEcCtD
Baclofen—Diarrhoea—Valproic Acid—epilepsy syndrome	9.48e-06	9.57e-05	CcSEcCtD
Baclofen—Nervous system disorder—Topiramate—epilepsy syndrome	9.48e-06	9.57e-05	CcSEcCtD
Baclofen—Feeling abnormal—Gabapentin—epilepsy syndrome	9.47e-06	9.56e-05	CcSEcCtD
Baclofen—Tachycardia—Topiramate—epilepsy syndrome	9.44e-06	9.52e-05	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CDC42—epilepsy syndrome	9.42e-06	0.000139	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GFAP—epilepsy syndrome	9.42e-06	0.000139	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL12—epilepsy syndrome	9.42e-06	0.000139	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GAL—epilepsy syndrome	9.42e-06	0.000139	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BDKRB2—epilepsy syndrome	9.42e-06	0.000139	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—POMC—epilepsy syndrome	9.41e-06	0.000138	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Gabapentin—epilepsy syndrome	9.4e-06	9.48e-05	CcSEcCtD
Baclofen—Skin disorder—Topiramate—epilepsy syndrome	9.39e-06	9.48e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AKT3—epilepsy syndrome	9.38e-06	0.000138	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PRKCB—epilepsy syndrome	9.38e-06	0.000138	CbGpPWpGaD
Baclofen—Hyperhidrosis—Topiramate—epilepsy syndrome	9.35e-06	9.43e-05	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—IL6ST—epilepsy syndrome	9.34e-06	0.000137	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP2—epilepsy syndrome	9.31e-06	0.000137	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CHRM3—epilepsy syndrome	9.31e-06	0.000137	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRM5—epilepsy syndrome	9.31e-06	0.000137	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CNR1—epilepsy syndrome	9.25e-06	0.000136	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUNB—epilepsy syndrome	9.25e-06	0.000136	CbGpPWpGaD
Baclofen—Anorexia—Topiramate—epilepsy syndrome	9.22e-06	9.3e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PLCB1—epilepsy syndrome	9.21e-06	0.000135	CbGpPWpGaD
Baclofen—Dizziness—Valproic Acid—epilepsy syndrome	9.17e-06	9.25e-05	CcSEcCtD
Baclofen—Urticaria—Gabapentin—epilepsy syndrome	9.13e-06	9.21e-05	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AVP—epilepsy syndrome	9.12e-06	0.000134	CbGpPWpGaD
Baclofen—Abdominal pain—Gabapentin—epilepsy syndrome	9.08e-06	9.17e-05	CcSEcCtD
Baclofen—Body temperature increased—Gabapentin—epilepsy syndrome	9.08e-06	9.17e-05	CcSEcCtD
Baclofen—Hypotension—Topiramate—epilepsy syndrome	9.03e-06	9.12e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HTR7—epilepsy syndrome	9.02e-06	0.000133	CbGpPWpGaD
Baclofen—Asthenia—Pregabalin—epilepsy syndrome	8.99e-06	9.08e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CX3CR1—epilepsy syndrome	8.93e-06	0.000131	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.9e-06	0.000131	CbGpPWpGaD
Baclofen—Pruritus—Pregabalin—epilepsy syndrome	8.87e-06	8.95e-05	CcSEcCtD
Baclofen—Vomiting—Valproic Acid—epilepsy syndrome	8.81e-06	8.9e-05	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.81e-06	8.89e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—BDKRB1—epilepsy syndrome	8.76e-06	0.000129	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CHRM2—epilepsy syndrome	8.76e-06	0.000129	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CX3CL1—epilepsy syndrome	8.76e-06	0.000129	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HBEGF—epilepsy syndrome	8.76e-06	0.000129	CbGpPWpGaD
Baclofen—Insomnia—Topiramate—epilepsy syndrome	8.74e-06	8.83e-05	CcSEcCtD
Baclofen—Rash—Valproic Acid—epilepsy syndrome	8.74e-06	8.82e-05	CcSEcCtD
Baclofen—Dermatitis—Valproic Acid—epilepsy syndrome	8.73e-06	8.81e-05	CcSEcCtD
Baclofen—Headache—Valproic Acid—epilepsy syndrome	8.68e-06	8.77e-05	CcSEcCtD
Baclofen—Paraesthesia—Topiramate—epilepsy syndrome	8.68e-06	8.76e-05	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.68e-06	0.000128	CbGpPWpGaD
Baclofen—Dyspnoea—Topiramate—epilepsy syndrome	8.62e-06	8.7e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—AKT3—epilepsy syndrome	8.6e-06	0.000126	CbGpPWpGaD
Baclofen—Somnolence—Topiramate—epilepsy syndrome	8.59e-06	8.68e-05	CcSEcCtD
Baclofen—Diarrhoea—Pregabalin—epilepsy syndrome	8.57e-06	8.65e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CDC42—epilepsy syndrome	8.56e-06	0.000126	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—POMC—epilepsy syndrome	8.54e-06	0.000126	CbGpPWpGaD
Baclofen—Dyspepsia—Topiramate—epilepsy syndrome	8.51e-06	8.59e-05	CcSEcCtD
Baclofen—Decreased appetite—Topiramate—epilepsy syndrome	8.4e-06	8.48e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ADAM10—epilepsy syndrome	8.4e-06	0.000123	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL2—epilepsy syndrome	8.36e-06	0.000123	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.35e-06	8.42e-05	CcSEcCtD
Baclofen—Fatigue—Topiramate—epilepsy syndrome	8.33e-06	8.41e-05	CcSEcCtD
Baclofen—Dizziness—Pregabalin—epilepsy syndrome	8.29e-06	8.36e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AVP—epilepsy syndrome	8.28e-06	0.000122	CbGpPWpGaD
Baclofen—Constipation—Topiramate—epilepsy syndrome	8.27e-06	8.34e-05	CcSEcCtD
Baclofen—Pain—Topiramate—epilepsy syndrome	8.27e-06	8.34e-05	CcSEcCtD
Baclofen—Asthenia—Gabapentin—epilepsy syndrome	8.24e-06	8.32e-05	CcSEcCtD
Baclofen—Nausea—Valproic Acid—epilepsy syndrome	8.23e-06	8.31e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HRH3—epilepsy syndrome	8.17e-06	0.00012	CbGpPWpGaD
Baclofen—Pruritus—Gabapentin—epilepsy syndrome	8.13e-06	8.21e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—OPRM1—epilepsy syndrome	8.04e-06	0.000118	CbGpPWpGaD
Baclofen—Vomiting—Pregabalin—epilepsy syndrome	7.97e-06	8.04e-05	CcSEcCtD
Baclofen—Feeling abnormal—Topiramate—epilepsy syndrome	7.97e-06	8.04e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—S100B—epilepsy syndrome	7.94e-06	0.000117	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.91e-06	7.98e-05	CcSEcCtD
Baclofen—Rash—Pregabalin—epilepsy syndrome	7.9e-06	7.98e-05	CcSEcCtD
Baclofen—Dermatitis—Pregabalin—epilepsy syndrome	7.89e-06	7.97e-05	CcSEcCtD
Baclofen—Diarrhoea—Gabapentin—epilepsy syndrome	7.86e-06	7.94e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SOCS3—epilepsy syndrome	7.86e-06	0.000116	CbGpPWpGaD
Baclofen—Headache—Pregabalin—epilepsy syndrome	7.85e-06	7.92e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CDC42—epilepsy syndrome	7.84e-06	0.000115	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCR5—epilepsy syndrome	7.76e-06	0.000114	CbGpPWpGaD
Baclofen—Urticaria—Topiramate—epilepsy syndrome	7.68e-06	7.75e-05	CcSEcCtD
Baclofen—Abdominal pain—Topiramate—epilepsy syndrome	7.64e-06	7.71e-05	CcSEcCtD
Baclofen—Body temperature increased—Topiramate—epilepsy syndrome	7.64e-06	7.71e-05	CcSEcCtD
Baclofen—Dizziness—Gabapentin—epilepsy syndrome	7.6e-06	7.67e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—AVP—epilepsy syndrome	7.59e-06	0.000112	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR3—epilepsy syndrome	7.59e-06	0.000112	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	7.59e-06	0.000112	CbGpPWpGaD
Baclofen—Nausea—Pregabalin—epilepsy syndrome	7.44e-06	7.51e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NPY—epilepsy syndrome	7.4e-06	0.000109	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ATP2A2—epilepsy syndrome	7.4e-06	0.000109	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.38e-06	0.000108	CbGpPWpGaD
Baclofen—Vomiting—Gabapentin—epilepsy syndrome	7.31e-06	7.37e-05	CcSEcCtD
Baclofen—Rash—Gabapentin—epilepsy syndrome	7.25e-06	7.31e-05	CcSEcCtD
Baclofen—Dermatitis—Gabapentin—epilepsy syndrome	7.24e-06	7.31e-05	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AGT—epilepsy syndrome	7.2e-06	0.000106	CbGpPWpGaD
Baclofen—Headache—Gabapentin—epilepsy syndrome	7.2e-06	7.27e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HES1—epilepsy syndrome	7.18e-06	0.000106	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL2—epilepsy syndrome	7.14e-06	0.000105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—OXT—epilepsy syndrome	7.14e-06	0.000105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HSPB1—epilepsy syndrome	7.14e-06	0.000105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL3—epilepsy syndrome	7.14e-06	0.000105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CRH—epilepsy syndrome	7.14e-06	0.000105	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCR5—epilepsy syndrome	7.04e-06	0.000104	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.04e-06	0.000103	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FYN—epilepsy syndrome	6.98e-06	0.000103	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—H2AFX—epilepsy syndrome	6.96e-06	0.000102	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MEF2C—epilepsy syndrome	6.94e-06	0.000102	CbGpPWpGaD
Baclofen—Asthenia—Topiramate—epilepsy syndrome	6.94e-06	7e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—HTR2A—epilepsy syndrome	6.89e-06	0.000101	CbGpPWpGaD
Baclofen—Pruritus—Topiramate—epilepsy syndrome	6.84e-06	6.9e-05	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	6.84e-06	0.000101	CbGpPWpGaD
Baclofen—Nausea—Gabapentin—epilepsy syndrome	6.83e-06	6.89e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.71e-06	9.87e-05	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.65e-06	9.79e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NGF—epilepsy syndrome	6.64e-06	9.76e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TSC1—epilepsy syndrome	6.64e-06	9.76e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTK2B—epilepsy syndrome	6.64e-06	9.76e-05	CbGpPWpGaD
Baclofen—Diarrhoea—Topiramate—epilepsy syndrome	6.61e-06	6.68e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AGT—epilepsy syndrome	6.54e-06	9.62e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCR5—epilepsy syndrome	6.46e-06	9.5e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR2—epilepsy syndrome	6.46e-06	9.5e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SST—epilepsy syndrome	6.46e-06	9.5e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NTRK2—epilepsy syndrome	6.46e-06	9.5e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DUSP6—epilepsy syndrome	6.4e-06	9.41e-05	CbGpPWpGaD
Baclofen—Dizziness—Topiramate—epilepsy syndrome	6.39e-06	6.45e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.32e-06	9.29e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR2A—epilepsy syndrome	6.32e-06	9.29e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PLAT—epilepsy syndrome	6.29e-06	9.25e-05	CbGpPWpGaD
Baclofen—Vomiting—Topiramate—epilepsy syndrome	6.15e-06	6.2e-05	CcSEcCtD
Baclofen—Rash—Topiramate—epilepsy syndrome	6.1e-06	6.15e-05	CcSEcCtD
Baclofen—Dermatitis—Topiramate—epilepsy syndrome	6.09e-06	6.15e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.07e-06	8.93e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL12—epilepsy syndrome	6.07e-06	8.93e-05	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—POMC—epilepsy syndrome	6.06e-06	8.91e-05	CbGpPWpGaD
Baclofen—Headache—Topiramate—epilepsy syndrome	6.06e-06	6.11e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.04e-06	8.89e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.02e-06	8.85e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TSC2—epilepsy syndrome	6e-06	8.83e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGT—epilepsy syndrome	5.99e-06	8.82e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUNB—epilepsy syndrome	5.96e-06	8.76e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CNR1—epilepsy syndrome	5.96e-06	8.76e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PLCB1—epilepsy syndrome	5.94e-06	8.73e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOE—epilepsy syndrome	5.87e-06	8.64e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR7—epilepsy syndrome	5.81e-06	8.55e-05	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.79e-06	8.51e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KDR—epilepsy syndrome	5.75e-06	8.46e-05	CbGpPWpGaD
Baclofen—Nausea—Topiramate—epilepsy syndrome	5.74e-06	5.8e-05	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.74e-06	8.44e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HBEGF—epilepsy syndrome	5.64e-06	8.3e-05	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.56e-06	8.17e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCB—epilepsy syndrome	5.54e-06	8.15e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT3—epilepsy syndrome	5.54e-06	8.15e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6ST—epilepsy syndrome	5.52e-06	8.11e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—POMC—epilepsy syndrome	5.5e-06	8.1e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADAM10—epilepsy syndrome	5.41e-06	7.96e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL2—epilepsy syndrome	5.39e-06	7.92e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—S100B—epilepsy syndrome	5.12e-06	7.52e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SOCS3—epilepsy syndrome	5.07e-06	7.45e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDC42—epilepsy syndrome	5.05e-06	7.43e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—POMC—epilepsy syndrome	5.05e-06	7.42e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL2—epilepsy syndrome	4.94e-06	7.26e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AVP—epilepsy syndrome	4.89e-06	7.2e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HES1—epilepsy syndrome	4.63e-06	6.8e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FYN—epilepsy syndrome	4.5e-06	6.62e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—H2AFX—epilepsy syndrome	4.48e-06	6.59e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MEF2C—epilepsy syndrome	4.48e-06	6.58e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF2—epilepsy syndrome	4.46e-06	6.56e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.33e-06	6.36e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NGF—epilepsy syndrome	4.28e-06	6.29e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR5—epilepsy syndrome	4.16e-06	6.12e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RELA—epilepsy syndrome	4.14e-06	6.09e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR2A—epilepsy syndrome	4.07e-06	5.99e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MTOR—epilepsy syndrome	4.06e-06	5.97e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TSC2—epilepsy syndrome	3.87e-06	5.69e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGT—epilepsy syndrome	3.86e-06	5.68e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOE—epilepsy syndrome	3.79e-06	5.57e-05	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.77e-06	5.55e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—epilepsy syndrome	3.74e-06	5.49e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KDR—epilepsy syndrome	3.71e-06	5.45e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUN—epilepsy syndrome	3.63e-06	5.34e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCB—epilepsy syndrome	3.57e-06	5.25e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6ST—epilepsy syndrome	3.56e-06	5.23e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP9—epilepsy syndrome	3.53e-06	5.19e-05	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.48e-06	5.11e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT1—epilepsy syndrome	3.42e-06	5.04e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SRC—epilepsy syndrome	3.26e-06	4.79e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—POMC—epilepsy syndrome	3.25e-06	4.78e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL2—epilepsy syndrome	3.18e-06	4.68e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—epilepsy syndrome	3.17e-06	4.66e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF2—epilepsy syndrome	2.88e-06	4.23e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RELA—epilepsy syndrome	2.67e-06	3.93e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MTOR—epilepsy syndrome	2.62e-06	3.85e-05	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.43e-06	3.57e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—epilepsy syndrome	2.41e-06	3.54e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUN—epilepsy syndrome	2.34e-06	3.44e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—epilepsy syndrome	2.28e-06	3.35e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—epilepsy syndrome	2.21e-06	3.25e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SRC—epilepsy syndrome	2.1e-06	3.08e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—epilepsy syndrome	2.04e-06	3e-05	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—epilepsy syndrome	2.02e-06	2.98e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—epilepsy syndrome	1.3e-06	1.92e-05	CbGpPWpGaD
